We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

MedImmune Licenses BioWa’s POTELLIGENT™ Technology

News   Dec 07, 2005

 
MedImmune Licenses BioWa’s POTELLIGENT™ Technology
 
 
 

RELATED ARTICLES

Genetically Predisposed to Depression? Get on the Treadmill!

News

Increased levels of physical activity can significantly reduce the odds of depression, even among people who are genetically predisposed to the condition, according to a new study.

READ MORE

ELeCt-ing a New Contender for Chemo Delivery

News

A new technique called ELeCt (erythrocyte-leveraged chemotherapy) aims to resolve the problems that come with using the age-old "Trojan Horse trick" to smuggle drug-loaded nanoparticles into cancerous lung tissue.

READ MORE

Blood Test Accurately Predicts Sepsis Severity

News

Researchers at Cincinnati Children’s report in Science Translational Medicine that they have developed and successfully tested a new rapid blood assay that measures five biomarkers and accurately predicts which patients are at low, medium or high risk for death from sepsis.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE